chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reported heart palpitations, shortness of breath and headache. Transferred to the ED. Feeling better 1/19. Will follow up with PCP.
Vomiting like nonstop; Very nauseated; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting like nonstop) and NAUSEA (Very nauseated) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced VOMITING (Vomiting like nonstop) and NAUSEA (Very nauseated). At the time of the report, VOMITING (Vomiting like nonstop) and NAUSEA (Very nauseated) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported events are consistent with the product safety profile
Initial information received on 14 October 2010 from a consumer/patient. An 80-year-old female patient with a past medical history of gastroesophageal reflux disease (GERD) and asthma, received an intramuscular dose of FLUZONE HIGH-DOSE, lot number unknown, in the right arm on 11 October 2010. Four hours later the patient reported that she "felt like there was a bold in her neck sticking out through her neck, with severe pain in her neck". She also had trouble swallowing, which lasted until 10:00 p.m. (exact duration not reported). In addition, she had a headache, could not lift her right arm and had shoulder stiffness and loss of right arm strength. The patient recovered from her symptoms on an unspecified date. Follow-up information was received 03 November 2010 from a health care professional. The FLUZONE HIGH-DOSE lot number was U3633AA and the patient had been immunized at 11:40 AM on 11 October 2010. The patient had no concurrent illness at the time of vaccination. The reporter had no additional information at the time of the report. Follow-up information was received 25 January 2011 from a consumer, who is also the patient. The patient was not seen by a physician and the event did not require treatment. According to the patient, by the next morning they were ok. List of documents held by sender: none.
After the Pfizer Covid19 vaccine was administered on the left deltoid, patient immediately developed a red and swollen area at the injection site. She also reported feeling dizzy and upset stomach. While seating on a recliner chair vital signs were taken between normal limits however, she continued to feel dizzy so I offered her to be transferred to the Emergency Department for further care; patient declined. During observation post vaccination, patient had one emesis and reported feeling better after, therefore she continue to feel dizzy and her skin clammy/pale. Vital signs 15 and 30  minutes pot vaccination were between normal limits.  Patient's husband was called and he arrived to transport patient home when she felt better.
Pt here for a wellness exam. Per clinic records patient was due for covid # 3 bivalent dose. Called mom to obtain verbal consent, mom did not disclosed of any booster given prior. After reviewing state records it appeared that patient had already obtained the covid bivalent dose. Inform mom of extra dose of the covid bivalent given to patient. Mom understood and was okay with the situation as she rather have patient be extra protected. Advised mom to observe patient for any adverse reaction. Mom understood.  Patient was observed in clinic for more than 30 minutes.
Case number PHEH2012US021623 is an initial spontaneous report received from a physician on 26 Oct 2012: This report refers to an adult female patient. She was vaccinated with the first dose of post exposure series of RABAVERT (batch number: unknown) intramuscularly on an unspecified date in Oct 2012. Three days after vaccination, she experienced a migraine-like headache and exhaustion. She received second dose of RABAVERT (batch number: unknown) intramuscularly on 25 Oct 2012 and experienced migraine-like headache, fatigue (see related case: PHEH2012US021823). The final outcome was reported as condition unchanged at the time of reporting. No further information about seriousness and causality was reported.
Pt was administered 1st dose of Moderna and developed hives on left arm within 15 minutes of administration. Pt had no other symptoms (no breathing issues, no itching, and rash, no swelling). Pt was examined by PCP (Dr.). Pt was provided Benadryl 25mg and was instructed to self monitor symptoms at home.
Large, red, warm, raised, itchy area around injection site.  Also swollen lymph node at collar bone on same side as injection.
Started feeling ill on 8/6/2021 with cold like symptoms. Congestion; bad cough; runny nose; slight shortness of breath, fatigue
Patient reported feeling dizzy and lightheaded within moments of receiving injection. BP obtained 134/69, HR 90, Sp02 96%. Patient did not lose consciousness. Provided with water and crackers, advised to stay seated. Symptoms resolved within 15 minutes. Patient was able to drive self home after event.
36 hours post vax, the pt developed a fine, non-pruritic, pinkish rash on his back, arms, groin and buttocks. Three days post vax, the rash began to spread to his legs and began to itch. He was seen by a physician. A throat culture was negative to Streptococcus. The pt was treated with Benadryl. The rash and itch persisted as of 01/25/2001.
I have been experiencing fatigue, muscle pain and weakness, fogginess, dizziness, headaches, a slight sore throat, light coughing. I started experiencing these symptoms a day after the second dose.
Fever, pain, arm pain, aches and chills for one week. Took TYLENOL. Symptoms began to develop 30 minutes following injection.
5PM has temp of 102. Gave baby Tylenol. At 2am had temp of 104.7. Called on call nurse told to give Tylenol and Ibuprofen at 3 hr intervals. Gave baby cool bath. Temp went down to 100.1. By 5AM temp was normal.
have the shingles shots,but I just got them again/suspected vaccination failure; just got them again; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (several years before the date of reporting).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 25-APR-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received the Shingles shots, but the patient just got them (shingles) again. According to the patient's doctor, it could had been worse if the patient had not got the shingles shots. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for herpes zoster were unknown at the time of reporting. Follow up would not be possible as no contact details were available.
I went on Paxlovid the same day on June 19th that I started to feel COVID-19 symptoms. I did not have any fever but I did have chills, I was feeling better after about 24- hours after taking prescription. After about 6-8 days I started to develop a sinus infection, but I also started testing positive for COVID-19. I was treated for it by my physician. Since COVID-19 I have had a really hard time regulating my body temperature and it typically takes me about a half an hour to an hour to be comfortable. I also seem to have an issue with my feet and it seems that my arthritis may have flared up due to the COVID-19 infection however unsure.
Immediate chest pain, difficulty breathing, dizziness, seizure-like activity. Medical records/DC summary received 10/9/2009 for 9/22-9/23/2009.  DC Dx reaction to flu shot, "Pseudoseizures". 48 y/o received seasonal influenza 9/22/2009 and developed chest pain, SOB, dizziness and seizure like activity. To ED, evaluated per Neuro with final DX of reaction to flu shot, "pseudoseizures".
Heartburn, more than mild but less than severe muscle pain throughout the body, inclusive of joint pain. The muscle pain lasted a full day and was more pronounced than the typical muscle pain you would feel with the flu. I wonder if the spike protein can mimic other proteins in the body and the immune system targeted those proteins in the muscle tissue.
pt recv vax & exp raised, red area size of soft ball w/blisters around the border;
Linear rash L forearm, itchy back, lesions bilateral lower legs beginning hours post injection.
Pt reported hives developing around right arm. Hives not itchy, warm to the touch, no open areas noted, bruise at injection site.
hot flashes; Sweating; bad taste; Body odor; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076cz1a) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Blood pressure high, High cholesterol, Obesity and Penicillin allergy.   On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 13-May-2022, the patient experienced HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor). At the time of the report, HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported.  The patient did not take any other medications or products within 2 weeks of starting COVID-19 treatment.  Device date was reported as 16-May-2022.
This non-serious initial spontaneous case, was received on 13-Sep-2017 from a pharmacist, concerning a 3-year-old female child. The patient's medical history and concomitant medications were not reported. On 06-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 195210A (as reported), expiry date: MAR-2018, route of administration, anatomical location: not reported). FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older explicitly coded as inappropriate age at vaccine administration. It was reported that, no adverse effects were noted. The outcome of the events was not reported. The reporter assessed the events as non-serious.
Participant immediately stiffened in chair, eyes open, pulse rapid. Moved to floor with assistance of two co-workers. Remained conscious. Ice applied to forehead and neck, legs elevated, BP 140/80, P 100. Skin - cool and clammy. Participant remained conscious, color pale. After 15 minutes, sat up and drank some water. Color improved, pink, skin warm and dry. After 20 minutes, assisted to chair, drank an Element H20. Requested some food. At 1 bite of bar and vomited 3 x @ 40 minutes. After initial incident, continued to observe. Patient did relate that this has occurred several times in past. BP 140/90, P 80 @ 12:15 PM. Alert and oriented- active- desired to return to work.
Patient was evaluated in Urgent Care 10-21-12. Treated for cellulitis. 4 x 5 inch area of erythema, warmth and tenderness on back of (L) arm. 10-22 patient re-evaluated in clinic for worsening swelling. Erythema, warmth and edema (L) posterior arm. Fullness of ulnar lymph nodes.
Main chronic adverse effect was rapid onset and progression of autoimmune disease VITILIGO in multiple areas of my body.  I have been receiving treatment for the last 2-3 months, with some improvement, yet symptoms and spread still increasing.
Patient has pre-existing Parkinson's disease on carbidopa/levodopa. Following first dose of SHINGRIX developed significant acute leg weakness, immobility which improved without specific treatment over several days.
pt had a skin rash around injection site. patient used oral benadryl and benadryl skin cream to decrease itching
ReceiveD COVID VACCINES 1/4/2021 / 2/1/2021 MoDernA, INc
shingles, and Postherpetic neuralgia and other zoster-related conditions; shingles, and Postherpetic neuralgia and other zoster-related conditions; shingles, and Postherpetic neuralgia and other zoster-related conditions; This spontaneous report was received from a lawyer referring to a patient of unknown age and gender. The patient's relevant medical history, drug reactions/allergies and concomitant medication were not reported. On or about 17-JUL-2010, the patient was vaccinated at the pharmacy with zoster vaccine live(ZOSTAVAX) for the long-term prevention of shingles and zoster-related conditions (strength, route, dosage schedule, lot number and expiration date were not reported).        On an unknown date, subsequent to zoster vaccine live(ZOSTAVAX) inoculation, the patient was treated by healthcare providers, at the medical office for shingles, and Postherpetic neuralgia and other zoster-related conditions. Consequently the patient suffered and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The outcome of herpes zoster, ill-defined disorder and post herpetic neuralgia was considered as not recovered.   The lawyer considered herpes zoster, ill-defined disorder and post herpetic neuralgia to be related to Zoster Vaccine Live(ZOSTAVAX).
the 2nd dose was given 10 days too early; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose was given 10 days too early) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005c21A and 045B21A) for COVID-19 vaccination.     Concomitant products included NICOTINE for Smoking cessation therapy, BENZTROPINE [BENZATROPINE], BISACODYL, DOCUSATE, HALOPERIDOL, HALOPERIDOL DECANOATE, LITHIUM CARBONATE and POLYETHYLENE GLYCOL [MACROGOL] for an unknown indication.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose was given 10 days too early). On 01-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose was given 10 days too early) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Chills, fatigue, shortness of breath, sore arm where injection administered, tightness of chest (like someone is stepping on my chest), worse than my 2nd dose. 2nd dose adverse reaction only lasted one full day after the shot administered.
Chest pain, confusion, headache, nausea, severe intermenstrual bleeding, severe menstrual cramps
LR stayed for 30 minutes for observation post vaccination and reported no adverse side effects. Today, 1-15-21, LR called to report that once she got to her car, she began to have a metallic taste in her mouth that was localized in the back only. She also had some minor tingling of the left side of her face. She sat in her car for an additional 10 minutes. The metallic taste only lasted about 15 minutes and the tingling sensation only lasted a minute or two.
Lethargy, irritability, high pitched screaming AM 21FEB followed by 15 min period unresponsiveness;
Child was seen for a URI without fever on the afternoon of 04/21/2005- was given Promethazine with codeine for her cough. Fever began in night and child had a seizure at home early the next afternoon where her parents took her to the ER
After vaccination on  Oct.  14,   without any warning signs,  On Oct. 18  at 8 am   I suffered cardiac arrest  while still in bed.  My husband called 911 and performed CPR.  Paramedics shocked me 3 times, transported me to the hospital where I was again unresponsive and revived.    I spent 9 days in the hospital.  I was released  Oct.  26  to go home.  I have
patient should have received flucelvax instead of fluad due to age. no issues as of yet
Patient received vaccine, a few moments later he stood up to walk out of vaccine area and became unsteady.  He briefly lost consciousness but awakened with his eyes opened within a few seconds.  The patient did fall to the floor, however his mother had placed an infant carrier seat in the doorway which broke his fall.  He was able to communicate with mother and pharmacist right away and said he did not get hurt.  He was given water, gold fish crackers after a few moments and his mother monitored him for the remaining 30 minutes in the lobby.  Patient left pharmacy feeling better
Shortly after administering the vaccine, some people out in the waiting area grabbed me and said patient's eyes rolled back and she passed out and fell forward.  She had mentioned that she was very anxious about the shot while I gave it to her.  After I came out to her, she was very pale and I gave her some water.  I had her call her boyfriend to come inside. One of the technicians called the squad to come check her out.  They did so, and they left shortly after.  She mentioned that they told her she could either go to the hospital and be observed or go home.  She said she wanted to go home.  She and her boyfriend went home
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, subsequent to inoculation, the pt was treated for shingles. The pt had and would continue suffering ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of shingles was unknown. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
Very bad pain in right arm.  And terrible pain under arm for many weeks.  Had mammogram which may have been skewed b/c of the shot.  The pain was almost unbearable under my arm that the shot was given in.  Possibly a swollen lymph node.  I started to have great anxiety thinking I had cancer.  It lasted months. I also had terrible pain in my right leg.  I still have pain in my leg.
Chronic abd pain, bloating, loss of appetite spring 2013. POTS - summer 2015. Fainting 11/16/12 - immed after vaccine.
Redness, swelling, hardness, pain at injection site and most of front of upper arm that has increased in intensity and size each day since vaccination.  On day 4 (Monday), approx 5 inches in diameter.
Had vaginal spotting and a breakthrough menstrual cycle. Have not had a menstrual for 5 yrs. Have a circulatory disorder and have had very bad rainout flares. The rainout risks her circulation and now it is in her feet. Has no history of eczema and not have a bad case in her ear canal.
it seemed it kind of knocked him out; This is a spontaneous report from a contactable consumer. This consumer (wife) reported for husband that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient got his Pfizer Covid 19 Vaccine, it seemed, it kind of knocked him out. It was also reported that the patient had the Pfizer and he didn't have a problem. The outcome was unknown.   The lot number for the vaccine bnt162b2 was not provided and will be requested during follow up.
Noted left upper arm was red and swollen while giving the child a bath (size of area was bigger than a 50 cents piece). Doesn't seem to be painful to child. Advised cool compresses today and warm compresses tomorrow.
This spontaneous report was received from a physician assistant refers to a 52 year old female patient. The patients medical history included history of chicken pox and no known drug allergies. On 07-JUN-2013, the patient was vaccinated with a dose of 0.5 ml ZOSTAVAX ,(lot # J001009, in the right arm). Concomitant therapies included SYNTHROID, MAXALT, and ZOCOR. On 08-JUN-2013, the patient experienced vesicular eruption at the site of injection at the dermatome C4-C5. The maximum temperature was 98 degree centigrade. There were no other systemic symptoms. The patient did not have recent exposure to chicken pox or shingles. The outcome of vesicular eruption at the site of injection was reported as recovering. Additional information is not expected.
CHILD'S DATE OF BIRTH WRITTEN AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY INDIVIDUAL IDENTIFYING AS FATHER. CHILD IDENTIFIED IN SYSTEM (#150125475) WITH DIFFERENT DATE OF BIRTH.  CHILD TOO YOUNG FOR VACCINE.